Reported results
- Total revenues were $11.3 million for the third quarter of 2026.
- Research and development expenses were $16.2 million for the third quarter of 2026.
- Selling, general and administrative expenses were $9.5 million for the third quarter of 2026.
- Net loss for the third quarter of 2026 was $14.0 million, or $0.03 per share.
- Lexicon had $183.2 million in cash and investments as of September 30, 2026.
Guidance
- Lexicon continues to expect topline results for SONATA-HCM in the first quarter of 2027.
- NDA resubmission for ZYNQUISTA is anticipated in the first quarter of 2027.
Price and volatility reaction
The stock moved +8.8% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved -7.8 vol points across the event (constant-maturity series — not the front-week crush).
| Measure | Value | Basis |
|---|---|---|
| Close before release | 1.48 | 2026-11-04 |
| Close after release | 1.61 | 2026-11-05 |
| Realised move | +8.8% | close to close |
| 30d ATM IV change | -7.8 vol pts | constant-maturity series, not the front expiry |
Source
The figures above come from the earnings release the company filed with the SEC on 2026-11-05 (8-K, Item 2.02). Read the original filing on sec.gov.
